Baird Slaps $99 Price Target on Onyx Pharmaceuticals (ONXX)
Tweet Send to a Friend
Get Alerts ONXX Hot Sheet
Price: $95.23 -1.01%
Rating Summary:
20 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
20 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade ONXX Now!
Baird maintained an Outperform rating on Onyx Pharmaceuticals (NASDAQ: ONXX) and raised its price target to $99.00.
Commenting on the company's earnings report, analyst Christopher Raymond said he was raising estimates and price target on a "surprisingly strong first quarterly print for Kyprolis".
"While two months of strong initial uptake does not completely validate our bullish survey work, we do think this number warrants a measurable upward revenue revision," said Raymond.
For an analyst ratings summary and ratings history on Onyx Pharmaceuticals click here. For more ratings news on Onyx Pharmaceuticals click here.
Shares of Onyx Pharmaceuticals closed at $80.33 yesterday, with a 52 week range of $35.73-$93.18.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Commenting on the company's earnings report, analyst Christopher Raymond said he was raising estimates and price target on a "surprisingly strong first quarterly print for Kyprolis".
"While two months of strong initial uptake does not completely validate our bullish survey work, we do think this number warrants a measurable upward revenue revision," said Raymond.
For an analyst ratings summary and ratings history on Onyx Pharmaceuticals click here. For more ratings news on Onyx Pharmaceuticals click here.
Shares of Onyx Pharmaceuticals closed at $80.33 yesterday, with a 52 week range of $35.73-$93.18.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Jefferies Bumps Zumiez (ZUMZ) Numbers Up, But Remains on Sidelines
- Toll Bros. (TOL) Estimates/PT Raised at Compass Point
- Janney Capital Trims Numbers on Buckle (BKE), Margins Peaking
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Analyst PT ChangeRelated Entities
Robert W Baird, Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
